Literature DB >> 7547229

Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma.

T Hirano1, B Franzén, K Uryu, K Okuzawa, A A Alaiya, F Vanky, L Rodrigues, Y Ebihara, H Kato, G Auer.   

Abstract

Two-dimensional polyacrylamide gel electrophoresis combined with a non-enzymatic sample preparation technique is useful for analysing clinical tumour material. Using these techniques, we analysed the relationship between the histopathological findings in primary lung malignancies and the expression of a number of unidentified polypeptides that were detected in the molecular weight region 20-35 kDa. In this study 45 cases of primary lung cancer (PLC) (21 cases of adenocarcinoma, ten cases of squamous cell carcinoma, five cases of large-cell carcinoma, one case of adenosquamous cell carcinoma, five cases of small-cell carcinoma and three cases of carcinoid tumour) were examined. For reference, a human diploid fibroblast cell line (W138) and normal peripheral lymphocytes were used. Sixteen polypeptides were judged to be associated with histopathological features. These polypeptides seem to be valuable as differentiation markers. The simultaneous evaluation of these polypeptides and some other proliferation markers (e.g. PCNA, PCNA 'satellite', Numatin/protein B23 and lamin B) seems to clarify the characteristics of each case of PLC. Furthermore, it is possible to classify PLC based on the two-dimensional electrophoresis findings, and this classification of PLC is suggested to reflect the biological features of the tumour more precisely than that based only on morphology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547229      PMCID: PMC2034017          DOI: 10.1038/bjc.1995.422

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Coexistence of desmin and the fibroblastic intermediate filament subunit in muscle and nonmuscle cells: identification and comparative peptide analysis.

Authors:  D L Gard; P B Bell; E Lazarides
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Nonenzymatic extraction of cells from clinical tumor material for analysis of gene expression by two-dimensional polyacrylamide gel electrophoresis.

Authors:  B Franzén; S Linder; K Okuzawa; H Kato; G Auer
Journal:  Electrophoresis       Date:  1993-10       Impact factor: 3.535

5.  Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity.

Authors:  J H Morrissey
Journal:  Anal Biochem       Date:  1981-11-01       Impact factor: 3.365

6.  Vimentin-derived proteins: differences between normal human fibroblasts and transformed human cells.

Authors:  D C Ochs; E H McConkey; N L Guard
Journal:  Exp Cell Res       Date:  1981-10       Impact factor: 3.905

7.  Cytoskeletal proteins used as marker of differentiation in mouse terato;carcinoma cells.

Authors:  D Paulin; N Forest; J Perreau
Journal:  J Mol Biol       Date:  1980-11-25       Impact factor: 5.469

8.  Pathogenesis of bronchial carcinoma, with special reference to morphogenesis and the influence on the bronchial mucosa of 20-methylcholanthrene and cigarette smoking.

Authors:  M Nasiell; E Carlens; G Auer; Y Hayata; H Kato; C Konaka; V Roger; K Nasiell; I Enstad
Journal:  Recent Results Cancer Res       Date:  1982

9.  Reversibility of bronchial cell atypia.

Authors:  G Auer; J Ono; M Nasiell; T Caspersson; H Kato; C Konaka; Y Hayata
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

10.  Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis.

Authors:  K Okuzawa; B Franzén; J Lindholm; S Linder; T Hirano; T Bergman; Y Ebihara; H Kato; G Auer
Journal:  Electrophoresis       Date:  1994 Mar-Apr       Impact factor: 3.535

View more
  9 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

2.  Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms.

Authors:  S F Moss; V Krivosheyev; A de Souza; K Chin; H P Gaetz; N Chaudhary; H J Worman; P R Holt
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

3.  Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis.

Authors:  Jeong Seok Hwa; Hyo Jin Park; Jae Hun Jung; Sung Chul Kam; Hyung Chul Park; Choong Won Kim; Kee Ryeon Kang; Jea Seog Hyun; Ky Hyun Chung
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

4.  Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.

Authors:  Peng Zhang; Yi-Ping Han; Ling Huang; Qiang Li; DA-Lie Ma
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

5.  Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.

Authors:  April Scott; Ravi Salgia
Journal:  Biomark Med       Date:  2008-12-01       Impact factor: 2.851

6.  The case for well-conducted experiments to validate statistical protocols for 2D gels: different pre-processing = different lists of significant proteins.

Authors:  Sreelatha Meleth; Jessy Deshane; Helen Kim
Journal:  BMC Biotechnol       Date:  2005-02-11       Impact factor: 2.563

7.  Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features.

Authors:  T Hirano; K Fujioka; B Franzèn; K Okuzawa; K Uryu; H Shibanuma; K Numata; C Konaka; Y Ebihara; M Takahashi; H Kato; G Auer
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A.

Authors:  T Hirano; G Auer; M Maeda; Y Hagiwara; S Okada; T Ohira; K Okuzawa; K Fujioka; B Franzén; N Hibi; T Seito; Y Ebihara; H Kato
Journal:  Jpn J Cancer Res       Date:  2000-10

9.  Napsin A Expression in Human Tumors and Normal Tissues.

Authors:  Sören Weidemann; Jan Lukas Böhle; Hendrina Contreras; Andreas M Luebke; Martina Kluth; Franziska Büscheck; Claudia Hube-Magg; Doris Höflmayer; Katharina Möller; Christoph Fraune; Christian Bernreuther; Michael Rink; Ronald Simon; Anne Menz; Andrea Hinsch; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Eike Burandt; Rainer Krech; David Dum; Till Krech; Andreas Marx; Sarah Minner
Journal:  Pathol Oncol Res       Date:  2021-04-20       Impact factor: 3.201

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.